Company intelligence / Profile preview

CellAxia

Huddinge, Sweden

Ownership: Private
Development stage: Other

Overview

CellAxia is a Swedish clinical-stage biotechnology company dedicated to developing innovative autologous cell therapies for cardiovascular diseases. The company's lead program, CX-01, utilizes CD133+ bone marrow-derived stem cells to promote tissue repair and improve cardiac function in patients with chronic heart failure. By leveraging a proprietary cell selection process, CellAxia aims to provide a regenerative medicine solution for conditions with high unmet medical needs. The company is currently advancing its lead candidate through Phase 2 clinical trials in collaboration with leading academic institutions in Scandinavia. Their approach focuses on the pro-angiogenic and regenerative potential of specific stem cell populations to restore heart muscle function.

Therapeutic areas: Cardiovascular
Modalities: Cell therapyBiologicStem cell therapy
Industry: Biotech

Drug pipeline

1 asset

3D-DCob

Preclinical

Partnerships

Karolinska InstitutetUppsala University

Beyond the preview

Go deeper on CellAxia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellAxia.

Explore the full profile